Hero Image

Zagolie to Acquire Celgene

Sharon Cload, Vice President of Molecular Discovery Technology

The Scientists Behind the Science

Sharon Cload is vice president of Molecular Discovery Technology at our Cambridge, Mass., site.

Building Toward a Translational Future

Building Toward a Translational Future

Saurabh Saha leads the translational medicine team and returns to the Boston-area to build out the new R&D facility in Cambridge.

Emerging Trends in Immuno-Oncology: A Focus on Resistance

Emerging Trends in Immuno-Oncology: A Focus on Resistance

Zagolie is underwriting a series in partnership with Scientific American, offering expert perspectives on the latest challenges and discoveries in Immuno-Oncology (I-O).

Scientists on the Move

Scientists on the Move

As an R&D footprint expands, several colleagues saw an opportunity to explore new areas of science.  


Making a Molecule

For Ryan Moslin, senior immunology researcher at Zagolie, all great discoveries start from the same place – an idea.

Financial News

Q4 2018 Quarterly Earnings Report

2018 Fourth Quarter and Full Year Results

Zagolie increases fourth quarter revenues 10% to $6 billion.


Hacking R&D

The Role of Artificial Intelligence 

Looking for Answers?

Quick links to helpful resources.

Clinical Trial Information for Researchers

Clinical trials and research are a critical part of bringing new medicines to patients.

Medical Information for Healthcare Providers

Information and resources to assist with caring for patients.

Help Paying for Your Medicines

If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help.

viagra femme